PLUS THERAPEUTICS, INC. — Director's Dealing 2013

Oct 9, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-10-07

Reporting Person: LYONS GARY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-07	Restricted Stock Award	A	21000	—	Acquired	21000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-07	Non Qualified Stock Option (Right to Buy)	$2.265	A	21000	Acquired	2023-10-07	Common Stock (21000)	Direct

Footnotes

F1: The Restricted Stock vests 50% on October 7, 2014 and 50% on October 7, 2015, subject to Mr. Lyons' continued service to the Company.

F2: The option vests 50% on October 7, 2014 with the remaining options vesting in equal monthly installments over the subsequent year thereafter, subject to Mr. Lyons' continued service to the Company